Opidep 50 Tablet contains Opipramol 50mg as its active ingredient, a tricyclic antidepressant primarily utilized in the management of anxiety and depressive disorders. Opipramol exerts its therapeutic effects by modulating neurotransmitter activity in the central nervous system, particularly through sigma receptor agonism, which contributes to anxiolytic and antidepressant properties without significant anticholinergic side effects commonly seen in other tricyclic antidepressants. Opidep 50 is indicated for the treatment of generalized anxiety disorder, somatoform disorders, and mild to moderate depression accompanied by anxiety symptoms. The medication is typically administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects may include drowsiness, dizziness, dry mouth, and gastrointestinal disturbances, which usually diminish with continued use. Caution is advised in patients with a history of cardiac conditions, glaucoma, or urinary retention. Opidep 50 should not be combined with monoamine oxidase inhibitors or other serotonergic agents due to the risk of serotonin syndrome. Regular monitoring by a healthcare professional is recommended to assess therapeutic efficacy and detect any potential side effects. This medication should be used under strict medical supervision, and abrupt discontinuation is discouraged to prevent withdrawal symptoms.